Candel Therapeutics, Inc.
NASDAQ:CADL
4.98 (USD) • At close April 25, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 102.654 | 35.413 | 70.058 | 82.642 | 35.053 | 5.179 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 39.878 |
| Cash and Short Term Investments
| 102.654 | 35.413 | 70.058 | 82.642 | 35.053 | 45.057 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 1.15 | 1.384 | 1.887 | 4.606 | 0.093 | 0.153 |
| Total Current Assets
| 103.804 | 36.797 | 71.945 | 84.945 | 35.146 | 45.21 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 2.733 | 4.022 | 5.48 | 3.836 | 2.787 | 0.425 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | -1.094 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0.266 | 0.424 | 0.266 | 0.266 |
| Tax Assets
| 0 | 0 | 0.828 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.329 | 0.382 | 0.266 | 0 | 0.083 | 0 |
| Total Non-Current Assets
| 3.062 | 4.404 | 5.746 | 4.26 | 3.136 | 0.691 |
| Total Assets
| 106.866 | 41.201 | 77.691 | 89.205 | 38.282 | 45.901 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 0.237 | 0.422 | 0.38 | 1.59 | 0.921 | 0.218 |
| Short Term Debt
| 10.461 | 9.406 | 0.928 | 0 | 0.463 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0.144 | 0 | 3.142 | 0 |
| Other Current Liabilities
| 26.831 | 4.356 | 4.307 | 3.772 | 3.329 | 1.192 |
| Total Current Liabilities
| 37.529 | 14.184 | 5.615 | 5.362 | 4.713 | 1.41 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 0.407 | 13.356 | 22.336 | 0.56 | 0.483 | 0.42 |
| Deferred Revenue Non-Current
| 0 | 0 | 0.144 | 0 | 0.125 | 0.25 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0.828 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 2.603 | 0.916 | 1.882 | 19.146 | 56.523 | 51.859 |
| Total Non-Current Liabilities
| 3.01 | 14.272 | 24.362 | 19.706 | 57.131 | 52.529 |
| Total Liabilities
| 40.539 | 28.456 | 29.977 | 25.068 | 61.844 | 53.939 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 89.205 | 49.06 | 49.06 |
| Common Stock
| 0.469 | 0.29 | 0.29 | 0.286 | 0.116 | 0.116 |
| Retained Earnings
| -192.205 | -137.028 | -99.089 | -80.295 | -44.171 | -26.491 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | -0 | -89.205 | -49.06 | -0.019 |
| Other Total Stockholders Equity
| 258.063 | 149.483 | 146.513 | 54.941 | 20.493 | -30.704 |
| Total Shareholders Equity
| 66.327 | 12.745 | -99.089 | 64.137 | -23.562 | -8.038 |
| Total Equity
| 66.327 | 12.745 | -99.089 | 64.137 | -23.562 | -8.038 |
| Total Liabilities & Shareholders Equity
| 106.866 | 41.201 | -69.112 | 89.205 | 38.282 | 45.901 |